GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by United Community Bank

United Community Bank raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2,891.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,107 shares of the company’s stock after buying an additional 1,070 shares during the period. United Community Bank’s holdings in GE HealthCare Technologies were worth $87,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in GEHC. Janney Montgomery Scott LLC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $4,367,000. QRG Capital Management Inc. boosted its position in shares of GE HealthCare Technologies by 7.3% during the 3rd quarter. QRG Capital Management Inc. now owns 7,128 shares of the company’s stock valued at $669,000 after purchasing an additional 485 shares in the last quarter. Graypoint LLC boosted its position in shares of GE HealthCare Technologies by 6.3% during the 3rd quarter. Graypoint LLC now owns 2,768 shares of the company’s stock valued at $260,000 after purchasing an additional 164 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Finally, SpiderRock Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 11.0% in the third quarter. SpiderRock Advisors LLC now owns 12,092 shares of the company’s stock worth $1,135,000 after buying an additional 1,198 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on GEHC shares. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup raised their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $86.58 on Monday. The firm has a market cap of $39.59 billion, a PE ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. The firm’s 50 day moving average price is $86.77 and its 200 day moving average price is $86.16. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.